Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisofylline Safety and Bioavailability in Type 1 Diabetes
NCT01603121Phase 2Terminated
- Sponsor
- Eastern Virginia Medical School
- Start
- Feb 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisofylline in type 1 diabetes mellitus (T1D), sponsored by Eastern Virginia Medical School. Started Feb 2012; status: terminated.
02
Drugs
lisofylline
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01603121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603121.